WallStreetZenWallStreetZen

NYSE: LLY
Eli Lilly & Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LLY

Based on 8 analysts offering 12 month price targets for Eli Lilly & Co

Min Forecast
$700.00-6.44%
Avg Forecast
$914.75+22.26%
Max Forecast
$1,135.00+51.7%

Should I buy or sell LLY stock?

Based on 8 analysts offering ratings for Eli Lilly & Co.

Strong Buy
Strong Buy
7 analysts 87.5%
Buy
0 analysts 0%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their LLY stock forecasts and price targets.

LLY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-27Find Out Why
lockedlocked$00.00+00.00%2025-08-13
lockedlocked$00.00+00.00%2025-08-13Find Out Why
lockedlocked$00.00+00.00%2025-08-11
lockedlocked$00.00+00.00%2025-08-08Find Out Why
JP Morgan
Top 23%
78
Strong BuyReiterates$1,100.00+47.02%2025-08-08Find out why
Morgan Stanley
Top 11%
90
Strong BuyMaintains$1,135.00+51.70%2025-07-10Find out why
Goldman Sachs
Bottom 46%
46
Strong BuyUpgrades$888.00+18.69%2025-04-08Find out why

1 of 1

Forecast return on equity

Is LLY forecast to generate an efficient return?

Company
240.26%
Industry
-2,075.93%
Market
-50.97%
LLY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LLY forecast to generate an efficient return on assets?

Company
43.5%
Industry
23.01%
LLY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LLY earnings per share forecast

What is LLY's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$23.20+51.11%
Avg 2 year Forecast
$30.94+101.59%
Avg 3 year Forecast
$38.49+150.76%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LLY revenue forecast

What is LLY's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$61.8B+16.05%
Avg 2 year Forecast
$73.8B+38.64%
Avg 3 year Forecast
$85.4B+60.42%
LLY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LLY earnings growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
35.91%
Industry
32.43%
Market
15.27%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LLY revenue growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
17.1%
Industry
6.68%
Market
10.84%
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LLY vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
LLY$748.19$914.75+22.26%Strong Buy
JNJ$177.40$175.80-0.90%Buy
ABBV$217.61$227.64+4.61%Buy
AZN$78.05N/AN/A
NVS$123.31$118.00-4.31%Strong Sell
View Top General Drug Manufacturer Stocks

Eli Lilly & Co Stock Forecast FAQ

Is Eli Lilly & Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: LLY) stock is to Strong Buy LLY stock.

Out of 8 analysts, 7 (87.5%) are recommending LLY as a Strong Buy, 0 (0%) are recommending LLY as a Buy, 1 (12.5%) are recommending LLY as a Hold, 0 (0%) are recommending LLY as a Sell, and 0 (0%) are recommending LLY as a Strong Sell.

If you're new to stock investing, here's how to buy Eli Lilly & Co stock.

What is LLY's earnings growth forecast for 2025-2027?

(NYSE: LLY) Eli Lilly & Co's forecast annual earnings growth rate of 35.91% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 32.43%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.27%.

Eli Lilly & Co's earnings in 2025 is $13,799,900,000.On average, 10 Wall Street analysts forecast LLY's earnings for 2025 to be $21,953,821,690, with the lowest LLY earnings forecast at $21,295,277,078, and the highest LLY earnings forecast at $24,314,474,139. On average, 11 Wall Street analysts forecast LLY's earnings for 2026 to be $29,287,631,179, with the lowest LLY earnings forecast at $26,018,096,305, and the highest LLY earnings forecast at $33,902,081,107.

In 2027, LLY is forecast to generate $36,430,824,276 in earnings, with the lowest earnings forecast at $32,359,356,590 and the highest earnings forecast at $40,924,790,259.

What is LLY's revenue growth forecast for 2025-2027?

(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 17.1% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Eli Lilly & Co's revenue in 2025 is $53,258,100,000.On average, 8 Wall Street analysts forecast LLY's revenue for 2025 to be $58,497,597,062,564, with the lowest LLY revenue forecast at $57,661,931,585,316, and the highest LLY revenue forecast at $60,963,847,584,377. On average, 8 Wall Street analysts forecast LLY's revenue for 2026 to be $69,881,678,337,776, with the lowest LLY revenue forecast at $63,423,960,334,108, and the highest LLY revenue forecast at $74,921,980,806,252.

In 2027, LLY is forecast to generate $80,862,856,756,508 in revenue, with the lowest revenue forecast at $72,868,652,332,169 and the highest revenue forecast at $87,015,548,782,972.

What is LLY's forecast return on assets (ROA) for 2025-2028?

(NYSE: LLY) forecast ROA is 43.5%, which is higher than the forecast US Drug Manufacturers - General industry average of 23.01%.

What is LLY's Price Target?

According to 8 Wall Street analysts that have issued a 1 year LLY price target, the average LLY price target is $914.75, with the highest LLY stock price forecast at $1,135.00 and the lowest LLY stock price forecast at $700.00.

On average, Wall Street analysts predict that Eli Lilly & Co's share price could reach $914.75 by Aug 27, 2026. The average Eli Lilly & Co stock price prediction forecasts a potential upside of 22.26% from the current LLY share price of $748.19.

What is LLY's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: LLY) Eli Lilly & Co's current Earnings Per Share (EPS) is $15.35. On average, analysts forecast that LLY's EPS will be $23.20 for 2025, with the lowest EPS forecast at $22.50, and the highest EPS forecast at $25.69. On average, analysts forecast that LLY's EPS will be $30.94 for 2026, with the lowest EPS forecast at $27.49, and the highest EPS forecast at $35.82. In 2027, LLY's EPS is forecast to hit $38.49 (min: $34.19, max: $43.24).

What is LLY's forecast return on equity (ROE) for 2025-2028?

(NYSE: LLY) forecast ROE is 240.26%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.